Hill-Rom Holdings Inc
NYSE:HRC
Intrinsic Value
Hill-Rom Holdings, Inc. operates as a medical technology company. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of HRC.
Fundamental Analysis
Balance Sheet Decomposition
Hill-Rom Holdings Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 271.8m |
Receivables | 671.2m |
Other Current Assets | 420.8m |
Non-Current Assets | 3.6B |
Long-Term Investments | 22.3m |
PP&E | 288.1m |
Intangibles | 955.3m |
Other Non-Current Assets | 2.4B |
Current Liabilities | 991.2m |
Accounts Payable | 229.9m |
Accrued Liabilities | 262.6m |
Other Current Liabilities | 498.7m |
Non-Current Liabilities | 2.1B |
Long-Term Debt | 1.8B |
Other Non-Current Liabilities | 303m |
Earnings Waterfall
Hill-Rom Holdings Inc
Revenue
|
3B
USD
|
Cost of Revenue
|
-1.4B
USD
|
Gross Profit
|
1.6B
USD
|
Operating Expenses
|
-1.1B
USD
|
Operating Income
|
525.4m
USD
|
Other Expenses
|
-276.9m
USD
|
Net Income
|
248.5m
USD
|
Free Cash Flow Analysis
Hill-Rom Holdings Inc
HRC Profitability Score
Profitability Due Diligence
Hill-Rom Holdings Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Hill-Rom Holdings Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
HRC Solvency Score
Solvency Due Diligence
Hill-Rom Holdings Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Hill-Rom Holdings Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HRC Price Targets Summary
Hill-Rom Holdings Inc
Shareholder Return
HRC Price
Hill-Rom Holdings Inc
Average Annual Return | 17.79% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -35% |
Market Capitalization | 10.3B USD |
Shares Outstanding | 66 050 500 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hill-Rom Holdings, Inc. operates as a medical technology company. The company is headquartered in Chicago, Illinois and currently employs 10,000 full-time employees. The firm's segments include Patient Support Systems, Front Line Care and Surgical Solutions. Patient Support Systems provides an ecosystem of digital and connected care solutions: devices, software, communications and integration technologies that improve care and deliver insights to caregivers and patients in the acute care setting. Front Line Care provides integrated patient monitoring and diagnostic technologies from hospital to home that enable and support its connected care strategy. Surgical Solutions enables peak procedural performance, connectivity and video integration products that improve collaboration, workflow, safety and efficiency in the operating room, such as surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. The firm also owns contact-free continuous monitoring technology.